Pfizer to takeover Actavis?

September 25, 2014 | Thursday | News | By BioSpectrum Bureau

Pfizer to takeover Actavis?

Yet another acquisition?

Yet another acquisition?

However, there has been no formal confirmations from both the companies yet.

This year, Pfizer was also keen on acquiring biopharmaceutical giant AstraZeneca for a staggering $118 billion.

But the discussions over the acquisition did not reach fruition.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy